HIV Infections: all 4,342 studies
Page 23 of 44. Open to participants first (242), then studies with results posted, then the rest; newest registration first within each.
- A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of IntelenceCompletedNCT01741844
- A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of PrezistaCompletedNCT01741831
- Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) CohortCompletedNCT01740115
- A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced SubjectsWithdrawnNCT01738555Phase 2
- A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects.TerminatedNCT01737359Phase 2
- A Study to Assess the Safety and Effectiveness of Darunavir for Treating Human Immunodeficiency Virus-Type I (HIV-1) Infection in Filipino PatientsWithdrawnNCT01726348
- Pilot Study to Assess the Efficacy of and Tolerance to a QUadruple Therapy to Treat HIV-HCV Coinfected Patients Previously Null RespondersCompletedNCT01725542Phase 2
- First Study to Evaluate the Capacity of Maraviroc Drug to Protect Against HIV Infection in Samples of Rectal Mucosa From Healthy VolunteersCompletedNCT01719627Phase 1
- Comparison of HIV Testing AlgorithmsCompletedNCT01716299
- Rapid Initiation of Antiretroviral Therapy to Promote Early HIV/AIDS Treatment in South Africa (RapIT Study)CompletedNCT01710397Not applicable
- Safety and Immunogenicity Study of SeV-G(NP) HIV Vaccine Administered Intranasally and Ad35-GRIN HIV Vaccine Given Intramuscularly in Prime-Boost Regimens in HIV-Uninfected VolunteersCompletedNCT01705990Phase 1
- Immune Reconstitution in HIV Disease (IREHIV)CompletedNCT01702974Phase 2
- A Pilot Study on Raltegravir, Tenofovir and Emtricitabine for Peri-exposure Prophylaxis for HIV InfectionStatus unknownNCT01697046Phase 3
- Positive Change Agents Program-Tanzania (Evaluation)CompletedNCT01693458Phase 3
- A Study on the Safety and Effectiveness of Rilpivirine Hydrochloride (Edurant) Among Adult Filipino Patients With Human Immunodeficiency Virus Type-I InfectionWithdrawnNCT01692470
- Brain Imaging for HIV-Associated Thinking and Mood DisordersTerminatedNCT01692236
- Microparticles, Vector of Genetic Information During HIV InfectionCompletedNCT01687452Not applicable
- Efficacy of HIV Post-Test Support for ANC in South AfricaCompletedNCT01683461Not applicable
- Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAARTCompletedNCT01680094Phase 1/2
- Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir StudyCompletedNCT01679964Phase 4
- Gut Associated Lymphatic Tissue (GALT) in HIV (Human Immunodeficiency Virus)- Infected PatientsCompletedNCT01679067
- Pilot Study of Diflunisal in HIV-infected AdultsTerminatedNCT01676363Phase 4
- Body Image in Youth With HIVCompletedNCT01673750
- Primary Care-Based Interventions to Reduce Alcohol Use Among HIV PatientsCompletedNCT01671501Not applicable
- Determination of Optimum Age for DXA Screening for Osteoporosis in HIV - The Probono 1 StudyCompletedNCT01669954
- Tripterygium Wilfordii Hook F (TwHF) Treatment for Immune Non-responders With HIV-1 InfectionStatus unknownNCT01666990Phase 1/2
- Relative Bioavailability Study of GSK1265744 FormulationsCompletedNCT01648257Phase 1
- Mobile Phone Technology for Prevention of Mother-to-Child Transmission of HIV: Acceptability, Effectiveness, and Cost (Kenya)CompletedNCT01645865
- BREATHER (PENTA 16) Short-Cycle Therapy (SCT) (5 Days on/2 Days Off) in Young People With Chronic HIV-infectionStatus unknownNCT01641016Phase 2/3
- A Study of Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Naïve HIV-1 Infected PatientsCompletedNCT01638650Phase 1
- Trends of Morbidity and Mortality Among Thai HIV-infected and HIV-uninfected Patients: a Five-year Prospective Cohort StudyCompletedNCT01634477
- Evaluation of Behavioral Intervention for HIV Positive Prisoners in NC and TXCompletedNCT01629316Not applicable
- Evaluation of the Bioequivalence of a Combined Formulated TabletCompletedNCT01622790Phase 1
- HIV Disclosure and Medication Adherence, a Pilot StudyCompletedNCT01621412
- Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum WomenCompletedNCT01621347
- Observational Study of HIV Infection in Participants of Seroconvert During Dapivirine Vaginal Ring TrialsCompletedNCT01618058
- Minority AIDS Initiative Retention and Re-Engagement ProjectCompletedNCT01616940Not applicable
- Fetal HIV Transmission Risk and Duration of Membrane RuptureCompletedNCT01616823
- An Observational Study to Evaluate Tolerability of PREZISTA or INTELENCE in HIV-1 Infected PatientsCompletedNCT01615601
- Predictors of Antiretroviral Pharmacokinetics in HIV-infected Women With Virologic SuppressionCompletedNCT01613157
- Linking Infectious and Narcology Care in RussiaCompletedNCT01612455Not applicable
- Peer-driven Intervention to Seek, Test & Treat Heterosexuals at High Risk for HIVCompletedNCT01607541Phase 2/3
- Darunavir Levels, Virological Efficacy, Proviral ADN and Resistances in Patients on Darunavir/Ritonavir MonotherapyCompletedNCT01606722
- Atazanavir/r + Lamivudine Dual TherapyCompletedNCT01599364Phase 4
- A Study to Evaluate the Bioequivalence of a Combined Formulated Tablet Compared With Maraviroc and Combivir™CompletedNCT01597648Phase 1
- International HIV Antiretroviral Adherence, Resistance and SurvivalCompletedNCT01596322
- A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Repeat Dose Administration of Long-Acting GSK1265744 and Long-Acting TMC278 Intramuscular and Subcutaneous Injections in Healthy Adult SubjectsCompletedNCT01593046Phase 1
- The Mochudi Prevention Project ART ProtocolTerminatedNCT01583439Not applicable
- Evaluating the Safety of and Immune Response to HIV-MAG DNA Vaccine With or Without Plasmid IL-12 Adjuvant Delivered Intramuscularly Via Electroporation Followed by VSV-gag HIV Vaccine Boost in Healthy, HIV-Uninfected AdultsCompletedNCT01578889Phase 1
- Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP)CompletedNCT01576731Phase 4
- A Study to Evaluate the Safety of the HIV-1 Vaccine MVA-B in Chronic HIV-1 Infected Patients Successfully Treated With HAARTCompletedNCT01571466Phase 1
- Positively Smoke Free on the Web (PSFW) for Smokers Living With HIVCompletedNCT01570595Phase 1/2
- A Study to Evaluate the Effect of Boceprevir and Telaprevir on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (ING115697).CompletedNCT01563328Phase 1
- Observational Study of Antiretroviral (ARV) Response in a Cohort of African Children Using Viral Load MonitoringWithdrawnNCT01555723
- Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in UgandaCompletedNCT01549509Phase 1
- Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in UgandaCompletedNCT01549470Phase 1
- Assessing the Safety of Dapivirine Gel and Film FormulationsCompletedNCT01548560Phase 1
- Mild Neurocognitive Disorder in HIV Infection of the BrainTerminatedNCT01547754
- Safety and Immune Response Assessment Study of Killed-whole HIV-1 Vaccine (SAV001-H) in Chronic HIV-1 Infected PatientsCompletedNCT01546818Phase 1
- Prospective Evaluation of Etravirine for HIV-infected Patients in Need of Lipid-lowering DrugsCompletedNCT01543035Phase 3
- A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment OutcomesStatus unknownNCT01541631Not applicable
- An Immunologic Study of Treatment-Naive HIV Patients Starting a Darunavir/Ritonavir- or Efavirenz-Based HAARTCompletedNCT01541085
- Dolutegravir Expanded Access StudyCompletedNCT01536873Not applicable
- Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP)CompletedNCT01533272Phase 4
- Use of Incentives to Engage Drug Users in HIV TherapyCompletedNCT01526421Not applicable
- Inflammation, Viral Replication, and Atherosclerosis in Treated HIV InfectionCompletedNCT01519141
- An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)CompletedNCT01513941Phase 3
- A Phase Il of a Therapeutic, Recombinant, Biologically Active HIV-1 Tat Protein Vaccine in HIV-Infected, Anti-Tat Negative, ARV-Treated Adult VolunteersCompletedNCT01513135Phase 2
- Perinatal Antiretroviral Intensification for PMTCT of HIV in Late ComersCompletedNCT01511237Phase 3
- Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV IncidenceCompletedNCT01509508Not applicable
- Rapid Oral Test for Therapeutic Response in HIV/AIDS PatientsCompletedNCT01507142
- Intervention for HIV-Positive Black Young Men Who Have Sex With Men (YMSM)CompletedNCT01502618Not applicable
- Drug Interaction Study Between Dolutegravir and an Oral Contraceptive Containing Norgestimate and EthinylestradiolCompletedNCT01498861Phase 1
- Safety and Immunogenicity Study of HIV-MAG Vaccine +/- IL-12 and Ad35-GRIN/ENV in HIV-uninfected VolunteersCompletedNCT01496989Phase 1
- Correlates of Oral Human Papillomavirus Infection in Adolescents and Young Adults With Behaviorally Acquired HIVCompletedNCT01492842
- Enhancement of Connect to Protect® (C2P)CompletedNCT01492816Not applicable
- Trial of Probiotics to Lower Microbial Translocation and Immune Activation in HIV-Infected AdolescentsWithdrawnNCT01492803Not applicable
- Evaluating the Safety of Tenofovir Vaginal Gel in HIV-Uninfected Pregnant WomenWithdrawnNCT01490671Phase 2
- Use of Incentives to Retain Drug Users in HIV TherapyCompletedNCT01488942Not applicable
- Evaluating the Immune Response to a rAd5 HIV Vaccine Administered in Three Different Ways in Healthy, HIV-Uninfected AdultsCompletedNCT01479296Phase 1
- Vitamin D Supplementation in HIVCompletedNCT01475890Phase 2/3
- Atazanavir/Ritonavir and Zinc Pharmacokinetic StudyCompletedNCT01475227Phase 4
- Intranasal Modified Vacc-4x Gag Peptides With Endocine as AdjuvantCompletedNCT01473810Phase 1/2
- On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With MenCompletedNCT01473472Phase 3
- Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral SuppressionCompletedNCT01471821Phase 4
- A Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 and Rilpivirine and Dolutegravir and Rilpivirine in Healthy Adult SubjectsCompletedNCT01467531Phase 1
- Methadone-Dolutegravir (DTG - GSK1349572) Drug Interaction Study.CompletedNCT01467518Phase 1
- Efficacy of Raltegravir in a Large Urban HIV Clinical Population in MilanCompletedNCT01467349
- Comparison of Door-to-door Versus Community Gathering to Provide HIV Counseling and Testing Services in Rural LesothoCompletedNCT01459120Not applicable
- A Commitment Device for Medication Adherence Among HIV PatientsCompletedNCT01455740Not applicable
- Early Antiviral Therapy for Critically Ill HIV Infected PatientsCompletedNCT01455688Phase 4
- RAltegravir Switch STudy: Effects on Endothelial RecoveryStatus unknownNCT01453933Phase 4
- The Efavirenz (EFV) Central Nervous System Exposure Sub-study of Encore1CompletedNCT01451333Phase 3
- Maternal-fetal CD4 Microchimerism in HiV Exposed Newborns After Spontaneous Delivery and Cesarean SectionCompletedNCT01450059
- Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody TestingCompletedNCT01447680
- An Exploratory Study of the Use of Five Wishes as a Tool for Advanced Care Planning in Young Adults With Metastatic, Recurrent, or Progressive Cancer or HIV InfectionCompletedNCT01445145
- Dimiracetam in Painful Neuropathies Affecting AIDS PatientsStatus unknownNCT01444690Phase 2
- Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment TrialWithdrawnNCT01442428Phase 2/3
- A Phase I Safety and Immunogenicity Preventive Vaccine Trial Based on the HIV-1 Tat and V2-deleted Env Proteins (ISS P-002)TerminatedNCT01441193Phase 1
- The Effect of Probiotics in HIV-1 InfectionCompletedNCT01439841Not applicable